MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at StockNews.com
Research analysts at StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Separately, D. Boral Capital reaffirmed a “buy” rating and issued a $9.00 target price on shares of MediciNova […]
Research analysts at StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Separately, D. Boral Capital reaffirmed a “buy” rating and issued a $9.00 target price on shares of MediciNova […]
